DianneDeplewskiMD
Pediatric Endocrinology • Chicago, ILPediatric Growth Disorder Endocrinology, Puberty Disorders/Pediatric Reproductive Endocrinology, Sex Differentiation Endocrinology
Associate Professor of Pediatrics, University of Chicago Medicine
Dr. Deplewski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-0443
Education & Training
University of ChicagoFellowship, Pediatric Endocrinology, 1993 - 1996
University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1990 - 1993
University of Illinois College of MedicineClass of 1990
Certifications & Licensure
IL State Medical License 1993 - 2026
WI State Medical License 1991 - 1993- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 51 citationsPeroxisome proliferator-activated receptors and skin development.Robert L. Rosenfield, Dianne Deplewski, Marianne E. Greene
Hormone Research. 2000-01-01 - 110 citationsGrowth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation.Dianne Deplewski, Robert L. Rosenfield
Endocrinology. 1999-09-01 - 109 citationsRat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors.Robert L. Rosenfield, Alex Kentsis, Dianne Deplewski, Nancy Ciletti
The Journal of Investigative Dermatology. 1999-02-01
Press Mentions
- Take the Shot: A Review of Vitamin K DeficiencyFebruary 1st, 2023
- Pediatric Obesity—a Looming Problem for the Pediatric PopulationFebruary 1st, 2023
- What Every Family with a Teenager Should Know—the Role of Naloxone in the Opioid CrisisFebruary 1st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
